Oryzon Genomics SA (ORYZF)
3.36
0.00 (0.00%)
USD |
OTCM |
Aug 21, 16:00
Oryzon Genomics Max Drawdown (5Y) : 70.44% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 70.44% |
| June 30, 2026 | 70.44% |
| May 31, 2026 | 70.44% |
| April 30, 2026 | 70.44% |
| March 31, 2026 | 70.44% |
| February 28, 2026 | 70.44% |
| January 31, 2026 | 70.44% |
| December 31, 2025 | 70.44% |
| November 30, 2025 | 70.44% |
| October 31, 2025 | 70.44% |
| September 30, 2025 | 70.44% |
| August 31, 2025 | 70.44% |
| July 31, 2025 | 70.44% |
| June 30, 2025 | 70.44% |
| May 31, 2025 | 70.44% |
| April 30, 2025 | 70.44% |
| March 31, 2025 | 70.44% |
| February 28, 2025 | 70.44% |
| January 31, 2025 | 70.44% |
| December 31, 2024 | 70.44% |
| November 30, 2024 | 70.44% |
| October 31, 2024 | 70.44% |
| September 30, 2024 | 70.44% |
| August 31, 2024 | 70.44% |
| July 31, 2024 | 70.44% |
| Date | Value |
|---|---|
| June 30, 2024 | 70.44% |
| May 31, 2024 | 70.44% |
| April 30, 2024 | 70.44% |
| March 31, 2024 | 64.36% |
| February 29, 2024 | 64.36% |
| January 31, 2024 | 64.36% |
| December 31, 2023 | 64.36% |
| November 30, 2023 | 64.36% |
| October 31, 2023 | 53.46% |
| September 30, 2023 | 53.46% |
| August 31, 2023 | 48.64% |
| July 31, 2023 | 48.64% |
| June 30, 2023 | 48.64% |
| May 31, 2023 | 48.64% |
| April 30, 2023 | 48.64% |
| March 31, 2023 | 48.64% |
| February 28, 2023 | 45.49% |
| January 31, 2023 | 45.49% |
| December 31, 2022 | 45.49% |
| November 30, 2022 | 45.49% |
| October 31, 2022 | 45.49% |
| September 30, 2022 | 45.49% |
| August 31, 2022 | 45.49% |
| July 31, 2022 | 45.49% |
| June 30, 2022 | 45.49% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Pharma Mar SA | 98.44% |
| Grifols SA | 77.82% |
| ACADIA Pharmaceuticals, Inc. | 77.18% |
| Alkermes Plc | 68.08% |
| Alnylam Pharmaceuticals, Inc. | 58.17% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -10.11 |
| Beta (5Y) | 0.3475 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 53.03% |
| Historical Sharpe Ratio (5Y) | -0.1303 |
| Historical Sortino (5Y) | -0.2631 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 18.75% |